News Sentiment

ASMB sentiment intelligence

Assembly Biosciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 27.40 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

82/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-1.2% over one week, +19.3% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Enterprise value to EBIT forward of Assembly Biosciences, Inc. – NASDAQ:ASMB

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 82/100 classification
One-week reaction -1.2% Price digesting
Trend fit Trend inactive 19.3% over four weeks
Fair value 50.5% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 45
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
TradingView 9
Stock Titan 8
TradingKey 5
simplywall.st 5
Stock Traders Daily 3
marketscreener.com 3
GlobeNewswire 3

Event Lens

What the news is about

Classified themes
Market update 37
Earnings 18
Analyst action 3
Balance sheet 2
Deals and strategy 1
Guidance 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 63
Stock Titan Direct company coverage

Assembly Biosciences (NASDAQ: ASMB) director receives 8,000 stock options grant

Assembly Biosciences director Lisa Johnson-Pratt was granted 8,000 stock options with an exercise price of $24.11 per share, expiring on June 4, 2036. The options vest upon the earlier of June 4, 2027, or the company's 2027 annual stockholder meeting, assuming continuous service.

Tone
Neutral 50/100
Event
Market update
Published
05 Jun 2026 23:08
Source
Stock Titan
Stock Titan Direct company coverage

Director at Assembly Biosciences (ASMB) receives grant of 8,000 stock options

Michael Houghton, a director at Assembly Biosciences (ASMB), has received a grant of 8,000 stock options. These options have an exercise price of $24.11 per share, expire on June 4, 2036, and will vest on the earlier of June 4, 2027, or the company's 2027 annual meeting of stockh

Tone
Neutral 50/100
Event
Market update
Published
05 Jun 2026 22:40
Source
Stock Titan
Stock Titan Direct company coverage

Assembly Biosciences (ASMB) director receives grant of 8,000 stock options

Assembly Biosciences (ASMB) director Susan Mahony was granted 8,000 stock options with an exercise price of $24.11 per share, expiring on June 4, 2036. The options will vest upon the earlier of June 4, 2027, or the company's 2027 annual meeting of stockholders, assuming continuou

Tone
Neutral 50/100
Event
Market update
Published
05 Jun 2026 22:40
Source
Stock Titan
Stock Titan Direct company coverage

Assembly Biosciences (ASMB) CMO awarded 14,000 restricted stock units

Assembly Biosciences' Chief Manufacturing Officer, Nicole S. White, was granted 14,000 restricted stock units (RSUs) as part of her annual equity compensation. This grant, approved on March 29, 2026, became issuable after stockholders approved an amendment to the company’s 2018 S

Tone
Neutral 50/100
Event
Market update
Published
05 Jun 2026 21:11
Source
Stock Titan